9C54
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 9c54 by Molmil](/molmil-images/mine/9c54) | |
9C56
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 9c56 by Molmil](/molmil-images/mine/9c56) | Crystal structure of human PTPN2 in complex with allosteric inhibitor | Descriptor: | 3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE, Tyrosine-protein phosphatase non-receptor type 2 | Authors: | Bester, S.M, Linwood, R, Wu, W.-I, Mou, T.-C. | Deposit date: | 2024-06-05 | Release date: | 2024-09-04 | Method: | X-RAY DIFFRACTION (2.43 Å) | Cite: | Enhancing the apo protein tyrosine phosphatase non-receptor type 2 crystal soaking strategy through inhibitor-accessible binding sites. Acta Crystallogr.,Sect.F, 2024
|
|
9C55
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 9c55 by Molmil](/molmil-images/mine/9c55) | Crystal structure of human PTPN2 in complex with active site inhibitor | Descriptor: | 5-(3-{[1-(BENZYLSULFONYL)PIPERIDIN-4-YL]AMINO}PHENYL)-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID, Tyrosine-protein phosphatase non-receptor type 2 | Authors: | Bester, S.M, Linwood, R, Wu, W.-I, Mou, T.-C. | Deposit date: | 2024-06-05 | Release date: | 2024-09-04 | Method: | X-RAY DIFFRACTION (2.36 Å) | Cite: | Enhancing the apo protein tyrosine phosphatase non-receptor type 2 crystal soaking strategy through inhibitor-accessible binding sites. Acta Crystallogr.,Sect.F, 2024
|
|